[1] Lee KH,Lee JM,Ji HP,et al.MR imaging in patients with suspected liver metastases:Value of liver-specific contrast agent gadoxetic acid. Korean J Radiol,2013,14(6):894-904. [2] Chen L,Zhang J,Zhang L,et al.Meta-analysis of gadoxetic acid disodium(Gd-EOB-DTPA)-enhanced magnetic resonance imaging for the detection of liver metastases. Plos One,2012,7(11):e48681. [3] Vreugdenburg TD,Ning M,Duncan JK,et al.Comparative diagnostic accuracy of hepatocyte-specific gadoxetic acid (Gd-EOB-DTPA) enhanced MR imaging and contrast enhanced CT for the detection of liver metastases:a systematic review and meta-analysis. Int J Colorectal Dis,2016,31(11):1739-1749. [4] Caraiani C,Dan M,Fenesan D,et al.Description of focal liver lesions with Gd-EOB-DTPA enhanced MRI. Clujul Med,2015,88(4):438-448. [5] Eun CY,Myeong-Jin K,Yeo-Eun K,et al.Correction: characterization of incidental liver lesions:Comparison of multidetector CT versus Gd-EOB-DTPA-enhanced MR imaging. Plos One,2013,8(6):e66141. [6] Wu WP,Hoi CI,Chen RC,et al.Comparison of the efficacy of Gd-EOB-DTPA-enhanced magnetic resonance imaging and magnetic resonance elastography in the detection and staging of hepatic fibrosis. Medicine,2017,96(42):e8339. [7] Kim YK,Park G,Kim CS,et al.Diagnostic efficacy of gadoxetic acid-enhanced MRI for the detection and characterisation of liver metastases:comparison with multidetector-row CT. Br J Radiol,2012,85(1013):539-547. [8] Granito A,Galassi M,Piscaglia F,et al.Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma:a prospective study. Aliment Pharmacol Ther,2013,37(3):355-363. [9] Park HH,Goo EH,Im IC,et al.Gd-EOB-DTPA-enhanced 3.0-Tesla MRI findings for the preoperative detection of focal liver lesions:Comparison with iodine-enhanced multi-detector computed tomography. J Korean Phys Soc,2012,61(11):1866-1876. [10] Haimerl M,Wachtler M,Zeman F,et al.Quantitative evaluation of enhancement patterns in focal solid liver lesions with Gd-EOB-DTPA-enhanced MRI. Plos One,2014,9(6):e100315. [11] Tamada T,Ito K,Ai UM,et al.Peripheral low intensity sign in hepatic hemangioma:Diagnostic pitfall in hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI of the liver. J Magn Reson Imaging,2012,35(4):852-858. [12] Verloh N,Haimerl M,Zeman F,et al.Multivariable analysis of clinical influence factors on liver enhancement of Gd-EOB-DTPA-enhanced 3T MRI. Rofo,2015,187(1):29-35. [13] Zhou ZP,Long LL,Qiu WJ,et al.Evaluating segmental liver function using T1 mapping on Gd-EOB-DTPA-enhanced MRI with a 3.0 Tesla. BMC Med Imaging,2017,17(1):20. [14] Bottcher J,Hansch A,Pfeil A,et al.Detection and classification of different liver lesions:comparison of Gd-EOB-DTPA-enhanced MRI versus multiphasic spiral CT in a clinical single centre investigation. Eur J Radiol,2013,82(11):1860-1869. [15] Peng Z,Li C,Chan T,et al.Quantitative evaluation of Gd-EOB-DTPA uptake in focal liver lesions by using T1 mapping: differences between hepatocellular carcinoma,hepatic focal nodular hyperplasia and cavernous hemangioma. Oncotarget,2017,8(39):65435-65444. [16] Liang M,Zhao J,Xie B,et al.MR liver imaging with Gd-EOB-DTPA:The need for different delay times of the hepatobiliary phase in patients with different liver function. Eur J Radiol,2016,85(3):546-552. [17] Wang YC,Chou CT,Lin CP,et al.The value of Gd-EOB-DTPA-enhanced MR imaging in characterizing cirrhotic nodules with atypical enhancement on Gd-DTPA-enhanced MR images. Plos One,2017,12(3):e0174594. [18] Haimerl M,Verloh N,Zeman F,et al.Gd-EOB-DTPA-enhanced MRI for evaluation of liver function:Comparison between signal-intensity-based indices and T1 relaxometry. Sci Rep,2017,7(1):43347. [19] Ogasawara G,Inoue Y,Matsunaga K,et al.Image non-uniformity correction for 3-T Gd-EOB-DTPA-enhanced MR imaging of the liver. Magn Reson Med Sci,2017,16(2):115-122. [20] 徐秀红,姜赛龙,蒋春兰. 超声弹性成像与常规超声诊断肝脏局灶性良恶性病变价值比较. 实用肝脏病杂志,2017,20(5):629-630. [21] 张宏春,耿喆. 增强CT扫描与超声造影对肝脏占位性病变的临床诊断价值比较. 实用肝脏病杂志,2016,19(6):696-699. [22] 佟晶,卑贵光,李玉泽,等. 钆塞酸二钠增强MR与增强CT在肝脏局灶性病变诊断中的对比研究. 中国临床医学影像杂志,2017,28(9):642-646. [23] 李小庆,周智鹏,何松青,等. 磁共振成像对比剂Gd-EOB-DTPA动态增强对肝脏局灶性病变的临床价值. 中华肝胆外科杂志,2013,19(11):815-820. [24] Golfieri R,Renzulli M,Lucidi V,et a1. Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to dynamic MRI in the detection of hypovascular small(≤2 cm) HCC in cirrhosis. Eur Radiol,2011,21(6):1233-1242. |